Hodgkin's lymphoma and acute lymphoblastic leukemia—two types of cancer that affect blood cells—do not respond adequately to treatment with CAR-T cells. The therapy involves harvesting the patient's ...

Teddi Mellencamp gave an update on her health, including her tumors and her body's response to immunotherapy, during the ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

However, the new immuno-based treatment would only require a single step — immunotherapy — to treat the cancer by teaching a person’s immune system to recognize and attack cancer cells.

Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...

New cancer research pioneered ... particularly vulnerable to a type of immunotherapy called "checkpoint inhibitors." This therapy "unmasks" tumor cells, MSK stated, making it easier for the ...

Researchers from MIT and Dana-Farber Cancer ... Immunotherapy treatments such as checkpoint blockade inhibitors, which are designed to help stimulate the body's own T cells to attack tumor cells ...

Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer. This procedure focuses on a special type of immune cell called T cells. These cells, particularly the subset ...

No other drugs, except for the immunotherapy treatment, dostarlimab, were given. Basically, it allows the immune system to recognize cancer cells and attack them, NBC News reported. Forty-nine ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from ...

Immunotherapy drugs work by teaching a person’s immune system to recognize and attack cancer cells. The drugs have been found to work particularly well against tumors with mismatch repair ...